Skip Navigation

Advanced Search

The global source for clinical trials information: offering news, analysis, study grants, career opportunities, and trial listings to professionals and patients.

Bookmark | Print | Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Psychiatry/Psychology

Clinical Trials: Schizophrenia and Schizoaffective Disorders


A listing of clinical trials currently looking for volunteers to enroll in Schizophrenia and Schizoaffective Disorders studies. Click on the closest city to find more detailed information on a research study in your area.

Arkansas

Little Rock : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

California

Anaheim : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Carson : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Cerritos : Comprehensive Clinical Development, Cerritos

Cerritos, CA - Schizophrenia

Cerritos : Comprehensive Clinical Development - Cerritos

Have you or a loved one been diagnosed with schizophrenia?

Costa Mesa : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Costa Mesa : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Culver : California Clinical Trials Medical Group, Inc.

Do you have schizophrenia or schizoaffective disorder?

Garden Grove : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Glendale : California Clinical Trials Medical Group, Inc.

An inpatient study comparing different types of the same study medication administered to subjects with schisophrenia, schizoaffective disorder, or schisophreniform disorder.

Glendale : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Glendale : CNS Healthcare

Schizophrenia and Schizoaffective Disorders Study

Imperial : Sun Valley Research Center

Diagnosed with Schizophrenia and Previous Trouble with the Law

Los Angeles : University of Southern California

Genetics of Schizophrenia

Los Angeles : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Norwalk : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Oakland : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Oceanside : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Orange : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Paramount : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Pasadena : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Riverside : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

San Diego : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

San Diego : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

San Francisco : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Santa Ana : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Sherman Oaks : Schuster Medical Research Institute

Schizophrenia Outpatient Clinical Research Study

Connecticut

Middletown : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

New Britain : The Hospital of Central Connecticut

Diagnosed with Schizophrenia and Previous Trouble with the Law? You are not alone. More people with serious mental illness in this country are in jails or prisons than in hospitals.

New Brittain : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Norwalk : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Florida

Jacksonville Beach : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Miami : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Miami : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Miami : Pharmax Research Clinic, Inc.

Schyzophrenia

Parkland : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Tampa : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Georgia

Atlanta : Comprehensive Clinical Development, Atlanta

Atlanta, GA - Schizophrenia

Atlanta : Comprehensive Clinical Development, Atlanta

Have you or a loved one been diagnosed with schizophrenia?

Atlanta : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Marietta : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Illinois

Chicago : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Chicago : Rush University Medical Center - Treatment Research Center

Schizophrenia Study

Hoffman Estates : Alexian Brothers Hospital Network

A 17-week, Phase 2, Multicenter, Randomized, Double-Blind Study of Treatment with LY2140023 Combined with SOC to placebo Combined with SOC as the Treatment of Patients with DSM-IV-TR Schizophrenia with Prominent Negative Symptoms

Hoffman Estates : Alexian Brothers Hospital Network

A double-blind, placebo and active controlled evaluation of the safety and efficacy of Cariprazine in the acute exacerbation of Schizophrenia

Hoffman Estates : Alexian Brothers Hospital Network

A fifteen month, prospective, randomized, active-controlled, open-label, flexible dose study of paliperidone palmitate compared with oral antipsychotic treatment in delaying time to treatment failure in adults with schizophrenia who have been recently released from jail.

Hoffman Estates : Alexian Brothers Hospital Network

A phase 2, multicenter, double-blind placebo-controlled comparator study of 2 doses of LY2140023 versus placebo in patients with DSM-IV-TR Schizophrenia.

Hoffman Estates : Alexian Brothers Hospital Network

A Phase III, multi-center randomized, 24 week, double-blind, parallel group, placebo controlled study to evaluate efficacy and safety of RO4917838 in stable patients with persistent, predominant negative symptoms of schizophrenia treated with antipsychotics followed by a 28 week, double-blind treatment period

Hoffman Estates : Alexian Brothers Hospital Network

A phase III, multicenter, randomized, 12-week, double-blind, parallel group, placebo controlled study to evaluate the efficacy and safety of R04917838 in patients with sub-optimally controlled symptoms of schizophrenia treated with antipsychotics followed by a 40-week double-blind, parallel-group, placebo controlled treatment period.

Hoffman Estates : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Joliet : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Naperville : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Kansas

Topeka : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Louisiana

Lake Charles : Lake Charles Clinical Trials

Assess long term safety, tolerability and effectiveness of lurasidone over a 12 month double blind period followed by a 6 month open label extension phase

Lake Charles : Lake Charles Clinical Trials

Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients

Lake Charles : Lake Charles Clinical Trials

Study to evaluate the efficacy tolerability, and safety of an intramuscular depot formulation of apripirazole as maintenance therapy in patients with schizophrenia

Lake Charles : Lake Charles Clinical Trials

To evaluate the efficacy and safety of Armodanifil as adjunctive therapy in adults with schizophrenia

Lake Charles : Lake Charles Clinical Trials

To evaluate the safety, efficiacy, and tolerability of cariprazine relative to placebo in patients with acute exacerbation of schizophrenia

Minnesota

Minneapolis : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Missouri

Creve Coeur : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Kansas City : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Saint Louis : Washington University in St. Louis - Center for Clinical Studies

Washington University seeks volunteers with schizophrenia.

St. Charles : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

St. Louis : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Nebraska

Lincoln : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

New Hampshire

Nashua : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

New Jersey

Cherry Hill : Center For Emotional Fitness

SCHIZOPHRENIA

Mount Laurel : CRI WW

Do you or a loved one suffer from Schizophrenia or Schizoaffective Disorder?

New Mexico

Albuquerque : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

New York

Amherst : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Brooklyn : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Buffalo : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Fresh Meadows : Comprehensive Clinical Development, Queens, NY

Have you been diagnosed with Schizophrenia?

Holliswood : Comprehensive Clinical Development, Queens, NY

Holliswood, NY - Schizophrenia

New York : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Rochester : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Wards Island : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Ohio

Akron : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Oklahoma

Oklahoma City : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Oklahoma City : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Pennsylvania

Allentown : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

McMurray : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Sellersville : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Tennessee

Franklin : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Memphin : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Memphis : Research Strategies of Memphis

Compare treatment of Schizophrenia in adult subjects

Memphis : Research Strategies of Memphis, LLC

Compare treatment of Schizophrenia in adult subjects

Texas

Austin : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Austin : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Dallas : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Houston : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Houston : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

San Antonio : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Wharton : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Washington

Kirkland : Research Center

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Washington, DC


Copyright © 1995-2012 CenterWatch.


Designed by Piehead Productions LLC.